Biomarkers Market By Type (Biomarker of Disease, Biomarker of Exposure), By Application (Disease Diagnosis, Disease Progression, Drug Discovery and Development, Development of Molecular Diagnostics, Forensic, Others), By End User (Hospitals, Research Organizations, Diagnostic Centers, Others)  and Geography


Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Biomarkers Market size was valued at USD 42.1 billion in 2021 and is projected to reach USD 94.2 billion by 2028 at a CAGR of 12.2% during the forecast period 2022 to 2028. Biomarkers are cellular or molecular diagnostic tools, measured in in biological samples, for instance, urine, stool and blood. It is utilized as an indicator to check and assess biological, pharmacological and pathogenic procedures. Biomarkers range from proteins, lipids, carbohydrates, RNA, DNA, hormones, platelets etc.  Currently wide range of biomarkers market are available for the different systems such as cardiovascular, metabolic system and immune system. Biomarkers not only help in diagnosis of the disease but also helps in tracking progression, regression and outcome after the intervention. Furthermore, biomarkers are also used in the drug development. Biomarkers of exposure and biomarkers of disease are the two major types of diagnostic biomarkers. Biomarkers of exposure are a new method for determining the quantity of harmful chemicals in a person's body. These biomarkers allow for the detection of aberrant activity and the calculation of the pre-disease state. Biomarkers of disease are used to identify disease conditions and to help validate clinical trials for new drugs. A perfect biomarker has specific qualities, such as being safe and easy to assess, being cost-effective to follow up on, and being changeable with treatment that is consistent across gender and ethnic groups. Biomarkers are used to predict serious illnesses like diabetes and cardiovascular disease, as well as cancer, neurological disorders, immunological disorders, and others. Every biomarker shows if a disease or a state of health exists, and they can be combined to give a complete picture of how healthy a person is and whether a diagnosis is required. Biomarkers are also employed in imaging technologies to give clear imaging of cancer tumours and other issues, as well as in clinical trials to identify the effect and effects of medications early on.

Biomarkers Market Summary

Study Period


Base Year




Largest Market

North America

Fastest Growing Market

Biomarkers Market

biomarkers market primarily driven by rise in demand and need for the accurate diagnosis of disease and progression of the intervention due to the increase in diseases like cancer and cardiovascular diseases. In addition, initiatives taken by the government and market players in biomarker research coupled with increase in the number of clinical research organizations are expected to boost the market over the forecast period. Furthermore, expansion of the applications of biomarkers in drug development and diagnostic segments projected to propel the growth of market in near future. On the other hand, high cost of discovery and development, poor reimbursement policies and technical issues in sample collection may hamper the market growth over the forecast period.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitors overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Biomarkers Market Segmentation

By Type
  • Biomarker of Disease
  • Biomarker of Exposure
By Application
  • Disease Diagnosis
  • Disease Progression
  • Drug Discovery and Development
  • Development of Molecular Diagnostics
  • Forensic
  • Others
By End User
  • Hospitals
  • Research Organizations
  • Diagnostic Centers
  • Others

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

[urltag url='request-table-of-content']

  • QIAGEN N.V. (Netherlands)
  • Merck Millipore (U.S.)
  • PerkinElmer, Inc. (U.S.)
  • Enzo Biochem, Inc. (U.S.)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • Siemens Healthineers (Germany)
  • Hoffmann-La Roche AG (Switzerland)
  • Thermo Fisher Scientific, Inc. (U.S.)
  • Abbott Laboratories (U.S.)